Health Boards
Wed-22-01-2014, 20:49 PM
Now Canada 
Interesting how they say 30% of Canadians may get PsA when the average I have found throughout the world is 20%. I wonder if it's due to the weather.
Still it's another plus for Stelara.
Quote:
Janssen Inc. announced today that Health Canada approved STELARA® (ustekinumab) for the treatment of adult patients with active psoriatic arthritis, alone or in combination with methotrexate. It is estimated that approximately 30 per cent of Canadians living with psoriasis may develop psoriatic arthritis.
Interesting how they say 30% of Canadians may get PsA when the average I have found throughout the world is 20%. I wonder if it's due to the weather.
Still it's another plus for Stelara.
